Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 3
1989 1
1991 2
1992 2
1993 1
1995 1
1996 2
1997 1
1998 2
1999 4
2000 2
2001 3
2002 3
2003 5
2004 3
2005 3
2006 5
2007 3
2008 3
2009 3
2010 6
2011 13
2012 3
2013 5
2014 12
2015 7
2016 9
2017 7
2018 6
2019 10
2020 16
2021 15
2022 5
2023 10
2024 24
2025 23
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer.
Turner NC, Im SA, Saura C, Juric D, Loibl S, Kalinsky K, Schmid P, Loi S, Sunpaweravong P, Musolino A, Li H, Zhang Q, Nowecki Z, Leung R, Thanopoulou E, Shankar N, Lei G, Stout TJ, Hutchinson KE, Schutzman JL, Song C, Jhaveri KL. Turner NC, et al. Among authors: shankar n. N Engl J Med. 2024 Oct 31;391(17):1584-1596. doi: 10.1056/NEJMoa2404625. N Engl J Med. 2024. PMID: 39476340 Clinical Trial.
Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer.
Jhaveri KL, Im SA, Saura C, Loibl S, Kalinsky K, Schmid P, Loi S, Thanopoulou E, Shankar N, Jin Y, Stout TJ, Clark TD, Song C, Juric D, Turner NC. Jhaveri KL, et al. Among authors: shankar n. N Engl J Med. 2025 Jul 10;393(2):151-161. doi: 10.1056/NEJMoa2501796. Epub 2025 May 31. N Engl J Med. 2025. PMID: 40454641 Clinical Trial.
Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer.
Jhaveri KL, Accordino MK, Bedard PL, Cervantes A, Gambardella V, Hamilton E, Italiano A, Kalinsky K, Krop IE, Oliveira M, Schmid P, Saura C, Turner NC, Varga A, Cheeti S, Hilz S, Hutchinson KE, Jin Y, Royer-Joo S, Peters U, Shankar N, Schutzman JL, Juric D. Jhaveri KL, et al. Among authors: shankar n. J Clin Oncol. 2024 Nov 20;42(33):3947-3956. doi: 10.1200/JCO.24.00110. Epub 2024 Sep 5. J Clin Oncol. 2024. PMID: 39236276 Free PMC article. Clinical Trial.
Congenital Lung Anomalies in Adults.
Mestas Nuñez M, Dulcich G, Restrepo CS, Khawaja R, Shankar N, Restauri N, Broncano J, Vargas D. Mestas Nuñez M, et al. Among authors: shankar n. Radiographics. 2024 Sep;44(9):e240017. doi: 10.1148/rg.240017. Radiographics. 2024. PMID: 39207925 Review.
Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study.
Bedard PL, Jhaveri KL, Accordino MK, Cervantes PA, Gambardella V, Hamilton E, Italiano PA, Kalinsky PK, Krop PIE, Oliveira M, Schmid PP, Saura C, Turner PN, Varga A, Cheeti S, Dey A, Hilz S, Hutchinson KE, Jin Y, Royer-Joo S, Peters U, Shankar N, Schutzman JL, Aimi J, Song K, Juric D. Bedard PL, et al. Among authors: shankar n. Eur J Cancer. 2025 May 15;221:115397. doi: 10.1016/j.ejca.2025.115397. Epub 2025 Mar 30. Eur J Cancer. 2025. PMID: 40203765 Free article. Clinical Trial.
Point-of-Care Ultrasound in Gastroenterology and Hepatology.
Shankar N, Kuo L, Krugliak Cleveland N, Galen B, Samel NS, Perez-Sanchez A, Nathanson R, Coss E, Echavarria J, Rubin DT, Soni NJ. Shankar N, et al. Clin Gastroenterol Hepatol. 2025 Jul;23(8):1277-1290. doi: 10.1016/j.cgh.2024.09.040. Epub 2025 Jan 8. Clin Gastroenterol Hepatol. 2025. PMID: 39793722 Free article. Review.
NAFLD: A pretransplant and post-transplant conundrum.
Rodas FV, Shankar N. Rodas FV, et al. Among authors: shankar n. Clin Liver Dis (Hoboken). 2023 May 8;21(4):93-98. doi: 10.1097/CLD.0000000000000021. eCollection 2023 Apr. Clin Liver Dis (Hoboken). 2023. PMID: 37936953 Free PMC article.
A Rare Pituitary Tumor.
Bhat R, Shankar N, Lu C, Srinivasa R, Rao S, Kalra P. Bhat R, et al. Among authors: shankar n. Cureus. 2024 Jun 27;16(6):e63264. doi: 10.7759/cureus.63264. eCollection 2024 Jun. Cureus. 2024. PMID: 39070413 Free PMC article.
Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation.
Kulkarni HS, Tague LK, Calabrese DR, Liao F, Liu Z, Garnica L, Shankar N, Wu X, Kulkarni DH, Bernardt C, Byers D, Chen C, Huang HJ, Witt CA, Hachem RR, Kreisel D, Atkinson JP, Greenland JR, Gelman AE. Kulkarni HS, et al. Among authors: shankar n. bioRxiv [Preprint]. 2024 Nov 18:2024.11.17.623951. doi: 10.1101/2024.11.17.623951. bioRxiv. 2024. Update in: J Clin Invest. 2025 Nov 11:e188891. doi: 10.1172/JCI188891. PMID: 39605452 Free PMC article. Updated. Preprint.
Pathogenesis and Models of Enterococcal Infection.
Garsin DA, Frank KL, Silanpää J, Ausubel FM, Hartke A, Shankar N, Murray BE. Garsin DA, et al. Among authors: shankar n. 2014 Feb 7. In: Gilmore MS, Clewell DB, Ike Y, Shankar N, editors. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection [Internet]. Boston: Massachusetts Eye and Ear Infirmary; 2014–. 2014 Feb 7. In: Gilmore MS, Clewell DB, Ike Y, Shankar N, editors. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection [Internet]. Boston: Massachusetts Eye and Ear Infirmary; 2014–. PMID: 24649512 Free Books & Documents. Review.
207 results